{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:38:24Z","timestamp":1792028304389,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11596-021-2397-z","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T06:03:41Z","timestamp":1629180221000},"page":"770-776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Treatment of Donor-derived Carbapenem-resistant Klebsiella pneumoniae Infection after Renal Transplantation with Tigecycline and Extended-infusion Meropenem"],"prefix":"10.1007","volume":"41","author":[{"given":"Zhi-qiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-liang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-yuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,17]]},"reference":[{"issue":"11","key":"2397_CR1","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrneph.2014.159","volume":"10","author":"JA Fishman","year":"2014","unstructured":"Fishman JA, Grossi PA. Donor-derived infection\u2013the challenge for transplant safety. Nat Rev Nephrol, 2014,10(11):663\u2013672","journal-title":"Nat Rev Nephrol"},{"issue":"Suppl 4","key":"2397_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/ajt.12095","volume":"13","author":"MG Ison","year":"2013","unstructured":"Ison MG, Grossi P, AST Infectious Diseases Community of Practice. Donor-derived infections in solid organ transplantation. Am J Transplant, 2013,13(Suppl 4):22\u201330","journal-title":"Am J Transplant"},{"issue":"6","key":"2397_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s11908-012-0300-6","volume":"14","author":"DR Kaul","year":"2012","unstructured":"Kaul DR. Donor-derived infection: epidemiology and outcomes. Curr Infect Dis Rep, 2012,14(6):676\u2013682","journal-title":"Curr Infect Dis Rep"},{"issue":"24","key":"2397_CR4","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1001\/jama.2008.896","volume":"300","author":"MJ Schwaber","year":"2008","unstructured":"Schwaber MJ, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA, 2008, 300(24):2911\u20132913","journal-title":"JAMA"},{"issue":"9","key":"2397_CR5","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/cid\/ciu052","volume":"58","author":"MJ Satlin","year":"2014","unstructured":"Satlin MJ, Jenkins SG, Walsh TJ. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis, 2014,58(9):1274\u20131283","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2397_CR6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1399-3062.2011.00688.x","volume":"14","author":"MD Bergamasco","year":"2012","unstructured":"Bergamasco MD, Barroso Barbosa M, de Oliveira Garcia D, et al. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation. Transpl Infect Dis, 2012, 14(2):198\u2013205","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"2397_CR7","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1111\/ajt.13317","volume":"15","author":"A Mularoni","year":"2015","unstructured":"Mularoni A, Bertani A, Vizzini G, et al. Outcome of Transplantation Using Organs From Donors Infected or Colonized With Carbapenem-Resistant Gram-Negative Bacteria. Am J Transplant, 2015,15(10):2674\u20132682","journal-title":"Am J Transplant"},{"issue":"4","key":"2397_CR8","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1128\/AAC.06268-11","volume":"56","author":"ZA Qureshi","year":"2012","unstructured":"Qureshi ZA, Paterson DL, Potoski BA, et al. Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens. Antimicrob Agents Chemother, 2012,56(4):2108\u20132113","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2397_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/1120009X.2018.1425279","volume":"30","author":"XR Bai","year":"2018","unstructured":"Bai XR, Liu JM, Jiang DC, et al. Efficacy and safety of tigecycline monotherapy versus combination therapy for the treatment of hospital-acquired pneumonia (HAP): a meta-analysis of cohort studies. J Chemother, 2018,30(3):172\u2013178","journal-title":"J Chemother"},{"issue":"Suppl 4","key":"2397_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/ajt.12096","volume":"13","author":"D van Duin","year":"2013","unstructured":"van Duin D, van Delden C, Practice ASTIDCo. Multidrug-resistant gram-negative bacteria infections in solid organ transplantation. Am J Transplant, 2013,13(Suppl 4):31\u201341","journal-title":"Am J Transplant"},{"issue":"7","key":"2397_CR11","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/cid\/cis588","volume":"55","author":"M Tumbarello","year":"2012","unstructured":"Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoiae: importance of combination therapy. Clin Infect Dis, 2012,55(7):943\u2013950","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2397_CR12","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1128\/AAC.06268-11","volume":"56","author":"ZA Qureshi","year":"2012","unstructured":"Qureshi ZA, Paterson DL, Potoski BA, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother, 2012,56(4):2108\u20132113","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"2397_CR13","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s10096-017-2936-5","volume":"36","author":"M Souli","year":"2017","unstructured":"Souli M, Karaiskos I, Masgala A, et al. Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis, 2017, 36(7):1305\u20131315","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"2397_CR14","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1097\/TP.0b013e318236cd02","volume":"92","author":"C Garzoni","year":"2011","unstructured":"Garzoni C, Ison MG. Uniform definitions for donor-derived infectious disease transmissions in solid organ transplantation. Transplantation, 2011,27;92(12):1297\u2013300","journal-title":"Transplantation"},{"issue":"5","key":"2397_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/tid.12276","volume":"16","author":"J Simkins","year":"2014","unstructured":"Simkins J, Muggia V, Cohen HW, et al. Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study. Transpl Infect Dis, 2014,16(5):775\u2013782","journal-title":"Transpl Infect Dis"},{"key":"2397_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13756-018-0355-8","volume":"7","author":"Y Wang","year":"2018","unstructured":"Wang Y, Lei H, Zhang Y, et al. Epidemiology of carbapenem-resistant Klebsiella pneumoniae bloodstream infections after renal transplantation from donation after cardiac death in a Chinese hospital: a case series analysis. Antimicrob Resist Infect Control, 2018, 7:66","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"2397_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijantimicag.2018.02.011","volume":"52","author":"BA Cunha","year":"2018","unstructured":"Cunha BA, Baron J, Cunha CB. Monotherapy with High-Dose Once-Daily Tigecycline is Highly Effective Against Acinetobacter baumanii and other Multidrug-Resistant (MDR) Gram-Negative Bacilli (GNB). Int J Antimicrob Agents, 2018,52(1):119\u2013120","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"2397_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/jcm7030049","volume":"7","author":"J Baron","year":"2018","unstructured":"Baron J, Cai S, Klein N, et al. Once Daily High Dose Tigecycline Is Optimal: Tigecycline PK\/PD Parameters Predict Clinical Effectiveness. J Clin Med, 2018,9;7(3):49","journal-title":"J Clin Med"},{"issue":"5","key":"2397_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00228-009-0631-x","volume":"65","author":"NR Srinivas","year":"2009","unstructured":"Srinivas NR. Tigecycline and cyclosporine interactionan interesting case of biliary-excreted drug enhancing the oral bioavailability of cyclosporine. Eur J Clin Pharmacol, 2009,65(5):543\u2013544","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"2397_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1053\/j.ajkd.2010.10.040","volume":"57","author":"M Pavan","year":"2011","unstructured":"Pavan M, Chaudhari AP, Ranganth R. Altered bioavailability of tacrolimus following intravenous administration of tigecycline. Am J Kidney Dis, 2011, 57(2):354","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2397_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/23744235.2017.1354259","volume":"50","author":"TE Bias","year":"2018","unstructured":"Bias TE, Malat GE, Lee DH, et al. Clinical outcomes associated with carbapenem resistant Klebsiella pneumoniae (CRKP) in abdominal solid organ transplant (SOT) recipients. Infect Dis, 2018,50(1):67\u201370","journal-title":"Infect Dis"},{"issue":"2","key":"2397_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/cid\/cix783","volume":"66","author":"D van Duin","year":"2018","unstructured":"van Duin D, Lok JJ, Earley M, et al. Antibacterial Resistance Leadership G. Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae. Clin Infect Dis, 2018,66(2):163\u2013171","journal-title":"Clin Infect Dis"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-021-2397-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-021-2397-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-021-2397-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T06:37:11Z","timestamp":1629182231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-021-2397-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["2397"],"URL":"https:\/\/doi.org\/10.1007\/s11596-021-2397-z","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"7 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors declared no competing interests. The clinical activities being reported are consistent with the principles of the declaration of Istanbul as outlined in the \u201cDeclaration of Istanbul on Organ Trafficking and Transplant Tourism\u201d.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}